Cornerstone Capital Inc. Cuts Holdings in Abbott Laboratories (NYSE:ABT)
Cornerstone Capital Inc. reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 4.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 241,640 shares of the healthcare product maker’s stock after selling 11,176 shares during the period. Abbott […]